News
Meet CILcare’s COO at Neurodegenerative Drug Development Summit on February 25-27 in Boston
Gaëlle NAERT, CILcare’s Chief Operations Officer, will attend the 8th Neurodegenerative Drug Development Summit, previously World CNS. The event will take place in Boston, USA on 25-27 of February 2020.
Meet CILcare at the Tech Tour Transfer Invest event on February 12-13 in Paris
Celia BELLINE, CEO of CILcare, and Dr. Wahid AWAD, Director of Business Strategy and Alliances, will attend the Tech Tour Transfer Invest event in Paris, France on 12-13 of February 2020. It is a perfect opportunity to connect with the best CRO partner for external...
CILcare’s CEO will attend the LSX World Congress on February 4-5 in London
Celia BELLINE, CEO of CILcare, will attend the 6th Annual Conference of LSX World Congress in London, UK on 4-5 of February 2020. She will give a presentation about CILcare on the 4th of February at 4:30 PM during the Biotech Inv€€$table Showcase. It is a perfect...
Meet CILcare at ARO Mid-Winter Meeting on January 25-29, 2020 in San Jose, USA
CILcare will be exhibiting at the ARO (Association for Research in Otolaryngology) Mid-Winter Meeting in San Jose, USA on 25-29 of January 2020 (booth #104). This year, our team will emphasize CILcare’s expertise in large animal models for auditory studies, as well as...
Meet CILcare’s CEO at J.P. Morgan Healthcare Conference on January 13-16, 2020 in San Francisco
Celia BELLINE, CEO of CILcare, will attend the J.P. Morgan Healthcare Conference in San Francisco, USA on 13-16 of January 2020. It is a perfect opportunity to meet her and learn about CILcare’s recent advances.
CILcare & Greensea, laureates with their project: “Microalgae, an innovative treatment for tinnitus”
Etienne Guyot, state prefect for the regions of Occitanie and the Haute-Garonne, and Didier Codorniou, first vice-president of the region of Occitanie and the Mediterranean-Pyrenees, handed over the prize to the winners of the Call for Proposals entitled “Avenir...
Watch new video to discover how CILcare & its partner Neuroservices-Alliance can assess your compound in pharmacological tinnitus models
CILcare & Neuroservices-Alliance, the leader in CNS electrophysiology and Behavior, combine their know-how in hearing & CNS disorders to offer you cutting-edge readouts to assess tinnitus. For instance, neuroprotective action of drug candidates in tinnitus can...
Peter Markham, CEO of our US partner CBSET, honored as “2019 Biomedical Research Business Leader” by Massachusetts Society for Medical Research
LEXINGTON, Mass., Oct. 24, 2019 — CBSET, a not-for-profit preclinical research institute dedicated to biomedical research, education, and advancement of medical technologies, announced today that its co-founder, president and chief executive officer, Peter Markham,...